Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 16039433

Facial implants.

Deborshi Roy·Devinder S Mangat
View original source ↗Export metadata ↓

Abstract

By offering safe, long-term correction of volume depletion and contour defects, facial implants maintain a unique position in the armamentarium of the cosmetic surgeon. Careful patient assessment and selection of the appropriate implant type, size, and shape maximize results. Proper postoperative follow-up helps to treat any complications before they become a serious problem. Most patients have volume loss as part of their facial aging. Facial implants play an important role in panfacial rejuvenation.

Explore related subjects

CheekChinHumansMaxillofacial ProsthesisRhytidoplastyJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Deborshi Roy, Devinder S Mangat. 2005. Facial implants.. https://doi.org/10.1016/j.det.2005.04.004

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Buccal plate excision for buccal paramandibular spread.

Cancer of buccal gingival sulcus lie in close proximity to mandible but tend to invade bone late in the course of disease. Segmental mandibulectomy advocated for these tumors results in cosmetic disfigurement and functional impairment. We, for the first time, describe a mandibular preservation alternative, in form of buccal cortical plate excision, for these tumors.

Cheek↗
PubMed2006

Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.

Benign tumors of the peripheral nerve sheath, termed neurofibromas, are the hallmark feature of neurofibromatosis type 1 (NF1). These tumors can result in hypertrophy of a limb or another anatomic region. Hemifacial hypertrophy due to an underlying neurofibroma is a typical manifestation of NF1 in young children although the overall frequency of facial involvement is low. We retrospectively studied all patients, which were referred to our outpatient clinic because of hemihypertrophy or swelling of the face for initially unknown reason with a final diagnosis of NF1. A total number of six patients were identified. Clinical and radiological characteristics of these patients were analyzed. In all patients, diagnosis of NF1 could be established based on the typical clinical criteria. However, despite other typical NF1-associated features (e.g. multiple café-au-lait spots) diagnosis of a plexiform neurofibroma as underlying cause for the hemifacial hypertrophy was significantly delayed in all patients. MRI scans were misinterpreted in all of the cases as lymphangioma because plexiform neurofibromas can resemble mesenchymal tumors or lymphangiomas. NF1 has to be considered in the differential diagnosis of hemifacial hypertrophy. A thorough clinical examination of affected patients should focus on typical disease-defining features. Early diagnosis of NF1 can prevent unnecessary treatment at least in some patients.

Cheek↗